On the public citation graph

Inhaled nintedanib is well-tolerated and delivers key pharmacokinetic parameters required to treat bleomycin-induced pulmonary fibrosis

https://doi.org/10.1016/j.pupt.2020.101938
0 signed · 69 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-4939-7113-8_2openalex-snapshot
The Bleomycin Model of Pulmonary Fibrosis
inferredcites →https://doi.org/10.1007/bf02714960openalex-snapshot
Localization of collagen in the rat lung: biochemical quantitation of types I and III collagen in small airways, vessels, and parenchyma
inferredcites →https://doi.org/10.1007/s00280-017-3452-0openalex-snapshot
Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis
inferredcites →https://doi.org/10.1007/s12161-015-0329-xopenalex-snapshot
Development of a Reference Measurement Procedure and Certified Reference Material for the Determination of Hydroxyproline in Meat
inferredcites →https://doi.org/10.1007/s40262-019-00766-0openalex-snapshot
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
inferredcites →https://doi.org/10.1016/j.bbadis.2013.03.001openalex-snapshot
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
inferredcites →https://doi.org/10.1016/j.pupt.2020.101933openalex-snapshot
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship
inferredcites →https://doi.org/10.1021/jm501562aopenalex-snapshot
Nintedanib: From Discovery to the Clinic
inferredcites →https://doi.org/10.1056/nejmoa1103690openalex-snapshot
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
inferredcites →https://doi.org/10.1056/nejmoa1402584openalex-snapshot
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
inferredcites →https://doi.org/10.1056/nejmoa1903076openalex-snapshot
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
inferredcites →https://doi.org/10.1056/nejmoa1908681openalex-snapshot
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
inferredcites →https://doi.org/10.1074/jbc.ra118.006615openalex-snapshot
Telomerase reverse transcriptase ameliorates lung fibrosis by protecting alveolar epithelial cells against senescence
inferredcites →https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5423openalex-snapshot
Respiratory Assessment Using Intra-Plural Pressure/Head-Out Plethysmography in a Repetitive Bleomycin Challenge Model of Pulmonary Fibrosis in Conscious Rats
inferredcites →https://doi.org/10.1164/rccm.2009-040glopenalex-snapshot
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
inferredcites →https://doi.org/10.1165/rcmb.2013-0310ocopenalex-snapshot
A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis
inferredcites →https://doi.org/10.1165/rcmb.2017-0096stopenalex-snapshot
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
inferredcites →https://doi.org/10.1177/0192623318761348openalex-snapshot
Use of Severity Grades to Characterize Histopathologic Changes
inferredcites →https://doi.org/10.1183/09031936.00152106openalex-snapshot
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
inferredcites →https://doi.org/10.1183/09031936.00174914openalex-snapshot
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
inferredcites →https://doi.org/10.1183/09031936.00185114openalex-snapshot
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
inferredcites →https://doi.org/10.1183/13993003.congress-2019.pa2422openalex-snapshot
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
inferredcites →https://doi.org/10.13140/rg.2.2.22715.64801openalex-snapshot
Inhaled Pirfenidone Improves Animal Efficacy Through Superior Pulmonary And Vascular Pharmacokinetics
inferredcites →https://doi.org/10.1371/journal.pone.0063432openalex-snapshot
Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology
inferredcites →https://doi.org/10.1371/journal.pone.0215565openalex-snapshot
A robust data-driven genomic signature for idiopathic pulmonary fibrosis with applications for translational model selection
inferredcites →https://doi.org/10.7326/0003-4819-134-2-200101160-00015openalex-snapshot
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4570632openalex-extracted
Development and Characterization of Nintedanib Inhalable Powders as a Potential Post Covid-19 Pulmonary Fibrosis Treatment
inferred← citeshttps://doi.org/10.1002/adma.202205083openalex-snapshot
Real‐Time Measurement of Cell Mechanics as a Clinically Relevant Readout of an In Vitro Lung Fibrosis Model Established on a Bioinspired Basement Membrane
inferred← citeshttps://doi.org/10.1002/anbr.202200106openalex-snapshot
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases
inferred← citeshttps://doi.org/10.1007/s00109-025-02593-2openalex-snapshot
Nintedanib reduces severity of post-traumatic joint contracture by modulating fibrosis and inflammation
inferred← citeshttps://doi.org/10.1007/s12247-026-10882-7openalex-snapshot
Inhalable Biopolymer-based Nanocomposites of Nintedanib Esylate: Design, Pharmacokinetics, Cytotoxicity and Antifibrotic Assessment
inferred← citeshttps://doi.org/10.1016/bs.apha.2023.04.002openalex-snapshot
Anti-fibrotic strategies and pulmonary fibrosis
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114831openalex-snapshot
Aerosol pulmonary immune engineering
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2025.115289openalex-snapshot
Nanotechnology-driven targeted pulmonary drug delivery: Innovations, insights, and clinical horizons
inferred← citeshttps://doi.org/10.1016/j.ejps.2024.106779openalex-snapshot
Preparation and evaluation of inhalable S-allylmercapto-N-acetylcysteine and nintedanib co-loaded liposomes for pulmonary fibrosis
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.123322openalex-snapshot
Long-circulating thiolated chitosan nanoparticles of nintedanib with N-acetyl cysteine for treating idiopathic pulmonary fibrosis: In vitro assessment of cytotoxicity, antioxidant, and antifibrotic potential
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.126088openalex-snapshot
Inhaled nintedanib dry powder formulation for the treatment of idiopathic pulmonary fibrosis: Pharmacodynamic and pharmacokinetic study
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104316openalex-snapshot
Breathing-induced stretch enhances the efficacy of an inhaled and orally delivered anti-fibrosis drug in vitro
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104716openalex-snapshot
Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.105233openalex-snapshot
Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105615openalex-snapshot
Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment – Evidence in disease-relevant in-vitro models
inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108682openalex-snapshot
From bench to clinical: Advances and prospects of siRNA inhalation therapy for idiopathic pulmonary fibrosis
inferred← citeshttps://doi.org/10.1016/j.pupt.2020.101933openalex-snapshot
Inhalation: A means to explore and optimize nintedanib's pharmacokinetic/pharmacodynamic relationship
inferred← citeshttps://doi.org/10.1016/j.rmr.2025.12.061openalex-snapshot
Les indications et modalités des traitements non usuels sous forme inhalée dans les pathologies respiratoires : une revue narrative
inferred← citeshttps://doi.org/10.1016/j.trim.2022.101608openalex-snapshot
Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts
inferred← citeshttps://doi.org/10.1016/j.xcrm.2026.102778openalex-snapshot
An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.4c01190openalex-snapshot
Dry Powder Inhalation of Nintedanib in Dibasic Calcium Phosphate for Targeting the Lungs in Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.1038/s41467-023-41272-zopenalex-snapshot
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
inferred← citeshttps://doi.org/10.1038/s41598-022-16843-7openalex-snapshot
Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
inferred← citeshttps://doi.org/10.1038/s41598-024-65030-3openalex-snapshot
Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis
inferred← citeshttps://doi.org/10.1039/d4tb01682copenalex-snapshot
Citrus pectin-coated inhalable PLGA nanoparticles for treatment of pulmonary fibrosis
inferred← citeshttps://doi.org/10.1080/10837450.2025.2611906openalex-snapshot
A comparative study of spray drying and jet milling in the preparation of nintedanib dry powder for inhalation
inferred← citeshttps://doi.org/10.1080/14728222.2025.2471579openalex-snapshot
Pharmacological targeting of ECM homeostasis, fibroblast activation and invasion for the treatment of pulmonary fibrosis
inferred← citeshttps://doi.org/10.1080/17425247.2021.1985460openalex-snapshot
Advances and challenges in nintedanib drug delivery
inferred← citeshttps://doi.org/10.1080/17425247.2026.2748249openalex-snapshot
Inhalation therapies in interstitial lung diseases
inferred← citeshttps://doi.org/10.1101/2025.11.12.687859openalex-snapshot
An aerosolised dual-action Autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis
inferred← citeshttps://doi.org/10.1111/bcpt.70220openalex-snapshot
Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.1183/16000617.0050-2021openalex-snapshot
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
inferred← citeshttps://doi.org/10.1186/s12951-024-02407-6openalex-snapshot
Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects
inferred← citeshttps://doi.org/10.2147/oarrr.s561159openalex-snapshot
Exploring Antifibrotic Strategies for Interstitial Lung Disease in Rheumatoid Arthritis: A Narrative Review
inferred← citeshttps://doi.org/10.3390/ijms22073331openalex-snapshot
Hypoxia Inducible Factor 1A Supports a Pro-Fibrotic Phenotype Loop in Idiopathic Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.3390/ijms24065204openalex-snapshot
Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma
inferred← citeshttps://doi.org/10.3390/jcm14134631openalex-snapshot
Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions
inferred← citeshttps://doi.org/10.3390/ph16020177openalex-snapshot
HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling
inferred← citeshttps://doi.org/10.3390/ph17101275openalex-snapshot
Optimization and Appraisal of Nintedanib-Loaded Mixed Polymeric Micelles as a Potential Nanovector for Non-Invasive Pulmonary Fibrosis Mitigation
inferred← citeshttps://doi.org/10.3390/ph17101360openalex-snapshot
Comparison of the Results of Modeling Pulmonary Fibrosis in Sprague Dawley Rats by Intratracheal Administration of Bleomycin in the Form of Sulfate and Chloride at a Dose of 3 mg/kg
inferred← citeshttps://doi.org/10.3390/pharmaceutics15122758openalex-snapshot
The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs
inferred← citeshttps://doi.org/10.3390/pharmaceutics16111391openalex-snapshot
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
inferred← citeshttps://doi.org/10.3390/pharmaceutics18020168openalex-snapshot
Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.